These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 24367707)
1. Abl family kinases regulate endothelial barrier function in vitro and in mice. Chislock EM; Pendergast AM PLoS One; 2013; 8(12):e85231. PubMed ID: 24367707 [TBL] [Abstract][Full Text] [Related]
2. Differential and opposing effects of imatinib on LPS- and ventilator-induced lung injury. Letsiou E; Rizzo AN; Sammani S; Naureckas P; Jacobson JR; Garcia JG; Dudek SM Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(3):L259-69. PubMed ID: 25480336 [TBL] [Abstract][Full Text] [Related]
3. Targeting Abl kinases to regulate vascular leak during sepsis and acute respiratory distress syndrome. Rizzo AN; Aman J; van Nieuw Amerongen GP; Dudek SM Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1071-9. PubMed ID: 25814671 [TBL] [Abstract][Full Text] [Related]
4. Effective treatment of edema and endothelial barrier dysfunction with imatinib. Aman J; van Bezu J; Damanafshan A; Huveneers S; Eringa EC; Vogel SM; Groeneveld AB; Vonk Noordegraaf A; van Hinsbergh VW; van Nieuw Amerongen GP Circulation; 2012 Dec; 126(23):2728-38. PubMed ID: 23099479 [TBL] [Abstract][Full Text] [Related]
5. Protein kinase G increases antioxidant function in lung microvascular endothelial cells by inhibiting the c-Abl tyrosine kinase. Stephens RS; Servinsky LE; Rentsendorj O; Kolb TM; Pfeifer A; Pearse DB Am J Physiol Cell Physiol; 2014 Mar; 306(6):C559-69. PubMed ID: 24401847 [TBL] [Abstract][Full Text] [Related]
6. Abl family kinases regulate FcγR-mediated phagocytosis in murine macrophages. Greuber EK; Pendergast AM J Immunol; 2012 Dec; 189(11):5382-92. PubMed ID: 23100514 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of platelet-derived growth factor receptor-alpha, -beta, c-kit, c-abl, and arg proteins in glioblastoma: possible implications for patient selection for imatinib mesylate therapy. Haberler C; Gelpi E; Marosi C; Rössler K; Birner P; Budka H; Hainfellner JA J Neurooncol; 2006 Jan; 76(2):105-9. PubMed ID: 16205964 [TBL] [Abstract][Full Text] [Related]
9. C-Abl inhibitor imatinib enhances insulin production by β cells: c-Abl negatively regulates insulin production via interfering with the expression of NKx2.2 and GLUT-2. Xia CQ; Zhang P; Li S; Yuan L; Xia T; Xie C; Clare-Salzler MJ PLoS One; 2014; 9(5):e97694. PubMed ID: 24835010 [TBL] [Abstract][Full Text] [Related]
10. Imatinib mesylate causes genome-wide transcriptional changes in systemic sclerosis fibroblasts in vitro. Hinchcliff M; Huang CC; Ishida W; Fang F; Lee J; Jafari N; Wilkes M; Bhattacharyya S; Leof E; Varga J Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S86-96. PubMed ID: 22691216 [TBL] [Abstract][Full Text] [Related]
11. Abl tyrosine kinase promotes dorsal ruffles but restrains lamellipodia extension during cell spreading on fibronectin. Jin H; Wang JY Mol Biol Cell; 2007 Oct; 18(10):4143-54. PubMed ID: 17686996 [TBL] [Abstract][Full Text] [Related]
12. Gleevec target Abl important for normal immune activation of T cells. Cancer Biol Ther; 2004 Aug; 3(8):704. PubMed ID: 15751157 [No Abstract] [Full Text] [Related]
13. PLK1 inhibitors synergistically potentiate HDAC inhibitor lethality in imatinib mesylate-sensitive or -resistant BCR/ABL+ leukemia cells in vitro and in vivo. Dasmahapatra G; Patel H; Nguyen T; Attkisson E; Grant S Clin Cancer Res; 2013 Jan; 19(2):404-14. PubMed ID: 23204129 [TBL] [Abstract][Full Text] [Related]
14. Imatinib mesylate stimulates low-density lipoprotein receptor-related protein 1-mediated ERK phosphorylation in insulin-producing cells. Fred RG; Boddeti SK; Lundberg M; Welsh N Clin Sci (Lond); 2015 Jan; 128(1):17-28. PubMed ID: 24865476 [TBL] [Abstract][Full Text] [Related]
15. The Abl and Arg kinases mediate distinct modes of phagocytosis and are required for maximal Leishmania infection. Wetzel DM; McMahon-Pratt D; Koleske AJ Mol Cell Biol; 2012 Aug; 32(15):3176-86. PubMed ID: 22665498 [TBL] [Abstract][Full Text] [Related]
16. Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib. Dewar AL; Cambareri AC; Zannettino AC; Miller BL; Doherty KV; Hughes TP; Lyons AB Blood; 2005 Apr; 105(8):3127-32. PubMed ID: 15637141 [TBL] [Abstract][Full Text] [Related]
17. Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression. Beppu K; Jaboine J; Merchant MS; Mackall CL; Thiele CJ J Natl Cancer Inst; 2004 Jan; 96(1):46-55. PubMed ID: 14709738 [TBL] [Abstract][Full Text] [Related]
18. Abl knockout differentially affects p130 Crk-associated substrate, vinculin, and paxillin in blood vessels of mice. Chen S; Wang R; Li QF; Tang DD Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H533-9. PubMed ID: 19542491 [TBL] [Abstract][Full Text] [Related]
20. Computational analysis of the binding specificity of Gleevec to Abl, c-Kit, Lck, and c-Src tyrosine kinases. Lin YL; Roux B J Am Chem Soc; 2013 Oct; 135(39):14741-53. PubMed ID: 24001034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]